Pharma

All articles by Pharma

Five things for pharma marketers to know: Tuesday, May 24, 2022
Five things for pharma marketers to know: Tuesday, May 24, 2022
Jack O'Brien
May 24, 2022
5:00 am

EU health agency warns Monkeypox could be endemic; FDA lifts clinical hold on Ocugen’s COVID vax trial; Moderna debuts on Fortune 500.

How marketers can navigate changing consumer expectations for healthcare
How marketers can navigate changing consumer expectations for healthcare
Jack O'Brien
May 23, 2022
3:13 pm

Data-driven strategies that focus on patient needs will provide pharma companies with more opportunity to reach increasingly elusive consumers.

Five things for pharma marketers to know: Monday, May 23, 2022
Five things for pharma marketers to know: Monday, May 23, 2022
Lecia Bushak
May 23, 2022
5:00 am

WHO calls emergency meeting to discuss growing Monkeypox outbreak; Telehealth abortion groups seek to bolster privacy defenses; Bayer pulls out of $670 million CAR-T partnership with Atara following patient death.

FDA greenlights Dupixent for eosinophilic esophagitis treatment
FDA greenlights Dupixent for eosinophilic esophagitis treatment
Jack O'Brien
May 20, 2022
4:05 pm

Dupixent has been a boon for the bottom lines of both Regeneron and Sanofi.

Five things for pharma marketers to know: Friday, May 20, 2022
Five things for pharma marketers to know: Friday, May 20, 2022
Jack O'Brien
May 20, 2022
5:00 am

CDC advisory committee approves COVID boosters for kids between 5-11; FDA head says the baby formula should ease ‘within days’; U.S. places $119 million order for 13 million Monkeypox vaccines.

Use of Pfizer, Merck antivirals rises in step with COVID case counts
Use of Pfizer, Merck antivirals rises in step with COVID case counts
Marc Iskowitz
May 19, 2022
9:31 am

Concurrent with the most recent wave of infections, providers are dispensing more of the antiviral pills, data show.

Five things for pharma marketers to know: Thursday, May 19, 2022
Five things for pharma marketers to know: Thursday, May 19, 2022
Lecia Bushak
May 19, 2022
5:00 am

U.S. health officials consider authorizing second booster shots for people under age 50; CDC notes concern over monkeypox outbreak in U.K.; Remix Therapeutics announces $70 million in new funding to develop RNA processing tech.

GlaxoSmithKline is now officially GSK
GlaxoSmithKline is now officially GSK
Lecia Bushak
May 18, 2022
3:48 pm

The pharma giant has gone by GSK both publicly and internally since Glaxo Wellcome and SmithKline Beecham merged 10 years ago.

‘Pharma Bro’ Martin Shkreli released from prison early
‘Pharma Bro’ Martin Shkreli released from prison early
Jack O'Brien
May 18, 2022
3:41 pm

Shkreli was sentenced to seven years in prison for securities fraud in 2018 and was denied an early release multiple times during the COVID-19 pandemic.

Dentsply Sirona’s internal probe for financial reporting causes late 10-Q filing, leads to Nasdaq listing notice
Dentsply Sirona’s internal probe for financial reporting causes late 10-Q filing, leads to Nasdaq listing notice
Jack O'Brien
May 18, 2022
9:42 am

The company’s former CFO, Jorge Gomez, resigned from his new role at Moderna after only two days due to the ongoing probe.

  • From Our Partners